Teva Pharmaceutical Industries Limited (TLV:TEVA)

Market Cap	121.52B +101.7%
Revenue (ttm)	51.58B +4.1%
Net Income	2.10B
EPS	1.79
Shares Out	n/a
PE Ratio	57.78
Forward PE	12.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	807,503
Open	10,430
Previous Close	10,430
Day's Range	10,290 - 10,500
52-Week Range	5,395 - 11,350
Beta	0.86
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 29, 2026

About TLV:TEVA

Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products, hormones, high-potency drugs, and cytotoxic substances in parenteral and solid dosage forms; and generic products with medical devices and combination products. The com...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1901
• Employees: 32,842
• Stock Exchange: Tel Aviv Stock Exchange
• Ticker Symbol: TEVA

Financial Performance

Financial numbers in USD

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 6, 2026

Data Sources Report a data error